28-Jul-2010 - b3c communications

Clontech Laboratories & TET Systems Announce the Broadening of Their License Agreement

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., and TET Systems, a privately-held German biotech company based in Heidelberg, announced that they have signed an amendment to their existing license agreement. Under the expanded license agreement, Clontech obtains rights to develop, manufacture and commercialize novel Tet Systems products as the Tet-On® 3G™ Inducible Expression System.

The Tet-On 3G Inducible Expression System provides highly inducible, sensitive control of gene expression. It includes two novel components, the rights to which were acquired by TET in 2009: (i) an improved transcriptional activator developed by scientists at the Academic Medical Center at the University of Amsterdam (AMC) in the Netherlands, and (ii) a novel minimal Tet promoter developed at the University of Heidelberg in Germany.

Facts, background information, dossiers
  • license agreements
  • TET Systems
  • Expression
  • Clontech Laboratories
  • Takara Bio
  • Netherlands
More about Takara Bio
  • News

    Takara Bio Europe Goes Direct in 2012

    Takara Bio Europe announced that it will start selling its range of Takara brand products exclusively and directly to customers in the UK, Germany, Austria and Switzerland, with immediate effect. The decision means customers will be able to buy both Takara and Clontech brand products from o ... more

    MDxHealth Licenses Methylation Technology to Takara Bio Inc. for Scientific Research Market

    MDxHealth SA announced that it has granted a non-exclusive worldwide license for its patented methylation specific PCR (MSP) technology to Takara Bio Inc.. Under the agreement, Takara Bio Inc. (Takara) has licensed the use of MDxHealth's MSP technology, the most widely applied methylation ... more

    Takara Bio to Acquire Clontech Unit of BD Biosciences

    Takara Bio Inc. announced that it has entered into a definitive agreement to acquire the Clontech unit ("Clontech") of BD Biosciences, mainly consisting of Clontech Laboratories Inc. (employees: 190), for USD $60 million (adjusted from USD $65 million due to the retention of certain invento ... more

  • Companies

    Takara Bio Europe S.A.S.

    Takara Bio Europe is a wholly owned subsidiary of Takara Bio Inc., who develops, manufactures, and distributes a wide range of life science reagents under the Takara™, Clontech®, and Cellartis® brands. Key products include SMART cDNA synthesis kits for a variety of samples and application ... more

More about TET Systems
  • News

    TET Systems and AMC/STW enter into an assignment agreement

    TET Systems Holding (TSH), the Academic Medical Center (AMC), and Technology Foundation STW announced that they have entered into an assignment agreement. Scientists at the AMC have previously developed a novel series of reverse transactivators with improved properties. Under the terms of t ... more

    TET Systems and Novo Nordisk sign license agreement

    TET Systems Holding GmbH & Co. KG announced that TET Systems and Novo Nordisk A/S have signed a license agreement allowing the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, the use of the Tet Technology for its internal research activities. “We are very ... more

    TET Systems and Pharmasset Settle Patent Litigation

    TET Systems Holding GmbH & Co. KG announced that TET Systems and Pharmasset, Inc. have settled patent litigation between the companies surrounding TET Systems’ patented gene expression technology. As part of the confidential settlement, the parties agreed to dismiss the litigation with pre ... more

  • Companies

    TET Systems Holding GmbH & Co.

    TET Systems Holding is a privately held company located in Heidelberg, Germany. TET Systems Holding was founded by Prof. Dr. H. Bujard and colleagues based on their invention of the Tet Technology, the most widely used method to control gene expression in higher organisms. TET Systems Hold ... more

More about Clontech Laboratories